Glenmark Pharma shares soar 8% on FDA clean report, Investec predicts 17% upside
- Posted on September 23, 2024
- By Business News Today
- 5 Views
Glenmark Pharma shares soar 8% on FDA clean report, Investec predicts 17% upside
The global brokerage firm said that it expects both earnings momentum and importantly cash flow generation to continue. Additionally, it sees Glenmark as more of an India / RoW play as these two contribute >70% of its EBITDA.
